Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04278404 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04278404 · ClinicalTrials.gov record · last posted 2026-08-21

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Study acronym: POPS or POP02
StatusRecruiting
PhaseNot specified
Started2020-03-05
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Protocol amendment history 2 changes detected by DataLookout

2026-08-22
Primary completion moved earlier: 2027-03 → 2026-11
2026-08-22
Completion moved earlier: 2027-07 → 2026-12
Trial Details
NCT Number NCT04278404
Lead Sponsor Duke University
Collaborators: The Emmes Company, LLC, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension, Pain, Hyperphosphatemia, Primary Hyperaldosteronism, Edema +17 more
Enrollment 5,000 participants
Start Date 2020-03-05
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-21